The current study showed a marked decrease in the immuno-markers RF, anti-CCP, and CRP serum levels in addition to water-rose levels in the groups treated with VIS and MTX with the lowest levels in the VIS-MTX combination group which following the results of MTX on RA patients obtained by [15]. The gene discussed is CRP; the disease is rheumatoid arthritis.